Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CLRN1 and FAM188B2 readthrough transcript (ENSG00000260234) refers to a naturally occurring fusion transcript that spans two adjacent genes: CLRN1, which encodes clarin-1 (a four-transmembrane protein crucial for neurosensory function in the inner ear and retina), and FAM188B2, whose function is poorly characterized. The readthrough is annotated based on transcriptional sequencing evidence but has no validated protein function, pathological association, or established therapeutic targeting relevance. Current disease links, biological functions, and molecular detail are all attributed to the canonical CLRN1 gene—not the readthrough form. This entity is not considered a receptor, enzyme, transporter, or transcription factor, and its therapeutic significance is unreported in the literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CLRN1 and FAM188B2 readthrough transcript.